What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Understanding Product Development in 503B Outsourcing Facilities

Understanding Product Development in 503B Outsourcing Facilities

Product development in 503B outsourcing facilities involves a detailed, highly regulated process. Every compounded medication produced by facilities like SCA Pharma must be safe, compliant, and aligned with the needs of healthcare institutions. This blog dives deeper into the product development process, covering each phase from discovery to post-launch monitoring.

The Product Development Process

The development of compounded medications requires diligence and precision. Every step ensures adherence to regulatory guidelines, such as current Good Manufacturing Practice (cGMP) regulations outlined by the FDA, and guarantees the utility and safety of the product for healthcare providers. Below is a detailed look at the five vital stages that SCA Pharma follows when creating new products. Read More >

SCA Pharma

SCA Pharma News & Announcements

SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. SCA Pharma offers a robust catalog, as well as outstanding quality and customer service.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Understanding Product Development in 503B Outsourcing Facilities

Name
Address
Subscribe